文献速递新生儿

新生儿复苏中肾上腺素的给药途径、剂量与间隔:系统综述

The Route, Dose, and Interval of Epinephrine for Neonatal Resuscitation: A Systematic Review.
PubMed 文献 · Pediatrics · 2020-09-09

该系统综述评估新生儿复苏中肾上腺素不同剂量、途径和间隔的给药方案,对比当前推荐的每3至5分钟静脉给予0.01至0.03 mg/kg。纳入的4项合格队列研究中仅2项提供可比较数据,未发现静脉与气管内给药在出院死亡、ROSC失败等结局上有差异;未检索到针对静脉剂量或给药间隔的人类婴儿研究。

要点

  • 静脉与气管内肾上腺素在出院死亡和ROSC相关结局上无显著差异。
  • 仅2项队列研究提供可比较数据,人类婴儿证据非常有限且确定性极低。
  • 未找到评估静脉剂量或给药间隔的人类婴儿研究。

核心结论

  • 气管内与静脉给予肾上腺素在存活率和其他结局上相似,但动物研究持续提示按当前推荐剂量静脉给药有益。

研究设计与样本

  • 系统综述检索Medline、Embase、CINAHL、Cochrane系统综述数据库和试验注册库,纳入比较新生儿复苏中其他剂量、途径或间隔与当前推荐静脉0.01至0.03 mg/kg每3至5分钟给药的人类婴儿及相关动物研究。

主要发现

  • 593条唯一检索记录中4项合格队列研究仅2项提供可比较数据;静脉与气管内给药在出院死亡风险比=1.03(95%CI 0.62至1.71)、未达到ROSC、达到ROSC时间(1项研究;50名婴儿)和接受额外肾上腺素比例(2项研究;97名婴儿)上无差异。
  • 1项研究比较2种气管内剂量,结局无差异。
  • 未发现评估静脉剂量或给药间隔的人类婴儿研究。

关键数值与推荐

  • 当前推荐方案为静脉给予0.01至0.03 mg/kg,每3至5分钟一次。
  • 静脉与气管内给药的出院死亡风险比=1.03(95%CI 0.62至1.71)。

临床怎么用

  • 现有极低确定性人类证据支持气管内与静脉肾上腺素在存活等结局上相似,但动物研究仍提示按当前推荐剂量静脉给药有益。

局限性

  • 人类证据稀疏且确定性极低,因严重偏倚风险和不精确性而降级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Current International Liaison Committee on Resuscitation recommendations on epinephrine administration during neonatal resuscitation were derived in 2010 from indirect evidence in animal or pediatric studies. OBJECTIVE: Systematic review of human infant and relevant animal studies comparing other doses, routes, and intervals of epinephrine administration in neonatal resuscitation with (currently recommended) administration of 0.01 to 0.03 mg/kg doses given intravenously (IV) every 3 to 5 minutes. DATA SOURCES: Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane Database of Systematic Reviews, and trial registry databases. STUDY SELECTION: Predefined criteria were used for selection. DATA EXTRACTION: Risk of bias was assessed by using published tools appropriate for the study type. Certainty of evidence was assessed by using Grading of Recommendations Assessment, Development and Evaluation. RESULTS: Only 2 of 4 eligible cohort studies among 593 unique retrieved records yielded data allowing comparisons. There were no differences between IV and endotracheal epinephrine for the primary outcome of death at hospital discharge (risk ratio = 1.03 [95% confidence interval 0.62 to 1.71]) or for failure to achieve return of spontaneous circulation, time to return of spontaneous circulation (1 study; 50 infants), or proportion receiving additional epinephrine (2 studies; 97 infants). There were no differences in outcomes between 2 endotracheal doses (1 study). No human infant studies were found in which authors addressed IV dose or dosing interval. LIMITATIONS: The search yielded sparse human evidence of very low certainty (downgraded for serious risk of bias and imprecision). CONCLUSIONS: Administration of epinephrine by endotracheal versus IV routes resulted in similar survival and other outcomes. However, in animal studies, researchers continue to suggest benefit of IV administration using currently recommended doses.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Isayama T, Mildenhall L, Schmölzer GM, et al. The Route, Dose, and Interval of Epinephrine for Neonatal Resuscitation: A Systematic Review. Pediatrics. 2020. PMID: 32907923. doi:10.1542/peds.2020-0586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。